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tissue samples on the basis of their expres-
sion profiles [1, 2]. This task presents a ma-
jor challenge due to the overwhelming
number of variables (genes), the majority
of which is not relevant to the description
of the problem and could potentially de-
grade the performance of the classification
scheme by masking the contribution of the
relevant features. Thus, together with the
development of classification schemes, it is
of paramount importance to identify those
genes that are most likely to confer high
classification accuracy (gene selection).
Indeed, these key informative features 
represent a base of reduced cardinality for
subsequent experimental investigation
aimed at determining their role, if any, in
the generation and progression of the ana-
lyzed phenotype.
The purpose of this work is to present 
a procedure for detecting patterns of ex-
pression correlated to peculiar phenotypes
through a supervised analysis of labeled
samples in the context of multiple tumor
types. Specifically, it presents results from 
a computational framework based on prin-
cipal component analysis (PCA) and on 
the Soft Independent Modeling of Class
Analogy (3). This approach simultaneously
allows identifying specific markers of phe-
notypes and predicting the class label of a
set of previously unseen instances.
The properties of principal component
analysis are used to implement a modeling
scheme called SIMCA, which has been pre-
viously applied to solve many pattern rec-
ognition and classification problems. In a
multi-class problem, SIMCA works consid-
ering each class separately. For each class, a
principal component analysis is performed
leading to a different PCA model for each
class (thus called disjoint class models).
Since the models are disjoint, the system
describing one class does not depend on
1. Introduction
High-throughput technologies are radically
boosting the understanding of living sys-
tems, thus creating enormous opportunities
to identify target genes and pathways for
drug development and to elucidate net-
works of genomic regulation by the com-
parison of the phenotype of cells in differ-
ent physiological states. At present, in the
so-called post-genomic era, the accent in 
biological research is shifting from data 
acquisition to data analysis and interpreta-
tion. Indeed, the increasing pace of genom-
ic data accumulation poses the challenge to
develop analysis procedures able to gener-
ate new knowledge and upgrade the infor-
mation content of these databases.
Several different methods have been
proposed to analyze large amounts of ex-
pression profiling data and identify set of
genes that can serve as diagnostic plat-
forms. Among all, the most widely used
technique is hierarchical agglomerative
clustering. As reported in many publica-
tions, clustering techniques have been ap-
plied to identify groups of genes sharing
similar expression profiles and the results
obtained so far are extremely valuable.
Clustering techniques have been demon-
strated to be useful tools in grouping func-
tional related families of genes. However,
clustering methodologies represent an ex-
ample of unsupervised analysis that is not
appropriate for the incorporation of prior
knowledge about the observations, as for
example sample labels (i.e., normal or tu-
mor tissue), in the partitioning and group-
ing procedure. As such, cluster analysis 
may not be a good framework for diagnosis
or classification of diseases nor to pinpoint
specific features marking a phenotype.
Several machine learning methods have
been applied to classify pathologies and 
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that of another category. When classifica-
tions of unknown samples are attempted,
a comparison is made between the un-
known’s data and each class model. The
model that best fits the unknown, if any,
represents the class assigned to that sample.
Even if reliable classification of previously
unseen instances is the ultimate goal of this
approach, SIMCA can also be used for the
fundamental issue of feature selection. In-
deed, examining the variance structure 
explained by each model, it is possible to
distinguish among the most important vari-
ables characterizing each single class and
identify specific genes most highly correlat-
ed with the tumor type distinctions.
The SIMCA modeling approach has
been applied to the analysis of two gene ex-
pression databases, namely the data set
from Golub’s work on leukemia classifica-
tion [1] and the study presented by Khan et
al. [2] on small round blue cell tumors.
2. Materials and Methods
2.1 Gene Expression Data from 
Tumor Samples
Two gene expression data sets have been
used to illustrate the gene selection and
classification method. The leukemia study
provides measurements for 3930 probes in
72 samples collected from acute leukemia
patients. Forty-seven cases were diagnosed
as acute lymphoblastic leukemia (ALL)
and the other 25, as acute myeloid leuke-
mia (AML). The ALL class was further
subdivided in 38 B-lineage and 9 T-lineage
ALL samples. RNA prepared from bone
marrow and peripheral blood cells was hy-
bridized to high-density oligonucleotide
microarrays, produced by Affymetrix (San-
ta Clara, CA).The second database consists
of gene-expression data from cDNA ex-
periments describing four childhood malig-
nancies: neuroblastoma (NB), rhabdomyo-
sarcoma (RMS), non-Hodgkin lymphoma
(NHL), and the Ewing family of tumors
(EWS). The 63 training samples included
both tumor biopsy material (13 EWS and
10 RMS) and cell lines (10 EWS, 10 RMS,
12 NB and 8 BL). An independent set of 
20 blind test samples has been used for 
testing the classification capabilities of the
proposed approach.
2.2 The SIMCA Method
Soft Independent Modelling of Class Anal-
ogy (SIMCA) uses PCA to extract different
characteristics from a set of objects. These
characteristics are then used to divide the
set into different classes, defined by the 
user. An object is classified as belonging to
the class it resembles the most. The method
is discussed in [3-4].
PCA is a statistical data analysis tech-
nique that allows reducing the dimension-
ality of the system while preserving infor-
mation on variable interactions [4]. PCA
transforms the original variables into a set
of linear combinations, the principal com-
ponents (PC), with special properties in
terms of variances. Specifically, it deter-
mines an optimal linear transformation y =
Wx of an n-dimensional data vector x into
another m-dimensional (m ! n) trans-
formed vector y. The mxn fixed linear
transformation matrix W is designed ex-
ploring statistical correlations among the
variables of the original data matrix and
finding reduced compact data representa-
tions that retain maximum nonredundant
and uncorrelated intrinsic information of
the original data. Exploration of the origi-
nal data set is based on computing and 
analyzing the data covariance matrix, its 
eigenvalues and corresponding eigenvec-
tors organized in descending order. Each
element of the m-dimensional transformed
feature vector y will be linearly inde-
pendent and in decreasing order according
to decreasing information content. This 
allows a straightforward reduction of the
dimensionality by discarding the feature
elements with lower information content.
Thus, all original n-dimensional data pat-
terns can be optimally transformed to data
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Table 1 B-ALL top 20 markers
patterns in a feature space with lower di-
mensionality. The algorithm chosen for this
work is based on singular value decomposi-
tion (SVD) and, since several texts cover
the calculation of the PC’s in details (e.g.,
[4]), theoretical aspects will be omitted.
Once a principal component model is cal-
culated, new object data can be projected
onto the PC vector space and the total resid-
uals between the predicted and the original
data represent a measure of how well the
projected data fit the original model. Com-
paring, through an F-test, the prediction 
errors with the residual limits calculated 
for the data used in the model construction
(training set), it is possible to see if the 
sample belongs to the modeled class or not.
With the SIMCA technique, different
classes are modeled individually by a separ-
ate principal component model. The num-
ber of significant PC’s is determined for
each class. The residuals are used for the
creation of boundaries around each class.
The distance or standard deviation sKk of
object k, described by m variables, to a class
K, modeled with pK principal components,
is given by the sum over the m variables of
the distances (or residuals) between object
k and the PC model along each variable 
j (eKkj).
A fundamental issue that can be ad-
dressed using the SIMCA modeling
scheme is variable selection, meaning the
identification of those peculiar features
that better characterize a category.The fea-
ture selection procedure comprises three
major steps: i) identification of those vari-
ables that best describe any given class (i.e.
the creation of class-specific lists of genes
based on the modeling power of the origi-
nal variables), ii) scoring and ranking of the
variables in each class-related list according
to their ability to discriminate the class they
model from all the other categories, iii)
computation of the minimum number of
variables needed to maximize multiclass
classification. Specifically, comparing the
different values of eKkj (i.e., the variance of
variable j of object k in class model K), it is
possible to sort and rank the different de-
scriptors of the system in terms of their
ability to describe a specific category while
discriminating among the different classes.
A class-K-variable is defined so that it
presents large values of the residuals when
class-K-samples are fitted to all categories
but the true K model and, at the same time,
the error of the K model is minimized only
by class-K-samples. The entire procedure
has been implemented in Matlab.
3. Results and Discussion
3.1 Leukemia Data Set
Following the experimental setup de-
scribed in [1], the data has been split into a
training set consisting of 38 samples (19 B-
ALL, 8 T-ALL, and 11 AML) and a blind
test set of 34 samples (19 B-ALL, 1 T-ALL,
and 14 AML).With the aim to first quantify
the relative relevance of each transcript in
describing the three different subtypes of
leukemia, three PCA models are built using
the three groups of training samples after
autoscaling the expression levels. A total of
4, 4, and 2 principal components accounting
for the 71.9, 73.2, and 88.5% of the overall
variance, respectively, describe the SIMCA
models. The number of principal compo-
nents has been determined using a leave-
one-out cross-validation procedure (details
described in [4]). Each of the 7129 vari-
ables have been assigned to one of the
classes analyzing the sum of the residuals
produced when a class-K-sample is fitted to
all models but the true one, checking, at 
the same time, the unique minimization of
model K residuals for class-K-samples only.
The selected genes have been finally sorted
combining their modeling power with their
discriminating power, among the different
classes. This procedure identifies 615 B-
lineage ALL, 2657 T-lineage ALL, and 
658 AML related transcripts. Tables 1, 2,
and 3 list the top 20 markers for each of the
three subtypes of leukemia. For all of these
features, experimental evidences prove or
suggest an important role in acute B-cell
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lymphoblastic, T-cell lymphoblastic, and
myeloid leukemias, respectively [1].
The accuracy in the classification of the
blind test set improves when using a subset
of the modeling features, as compared to all
the transcripts or to any random selection
of them. Indeed, the classification accuracy
arises from 53 % of correct predictions
when using all the expression profiles to 
82 % of correct predictions using the top
20÷40 markers identified by the SIMCA
approach. The definition of  unified criteria
for the selection of an optimal (or near 
optimal) subset of markers is under devel-
opment.
3.2 Small, Round Blue Cell Tumor
Data Set
The 63 training samples included both 
tumor biopsy material and cell lines for a
total of 4 different categories (EWS, RMS,
NB, and BL). An independent set of 20
blind test samples has been used for testing
the classification capabilities of the pro-
posed approach. Similarly to case study 1,
SIMCA modeling scheme identifies 600,
496, 512, and 700 genes related to EWS,
RMS, NB, and BL respectively. For sake of
space, Table 4 lists only the top 15 markers
of each category. Most of these transcripts
are included in Khan’s list of top ranking
genes [2]. The classification accuracy im-
proved from 10 % of correct calls, obtained
designing the classifier with all the 2308
genes, to 95 % when using only the top
10÷15 markers of each category.
4. Conclusions
DNA microarrays are radically boosting
the understanding of living systems, thus
creating enormous opportunities to eluci-
date the biological processes of cells in 
different physiological states. In particular,
the application of high-throughput technol-
ogies is improving cancer analysis to levels
that classical methods have been unable to
reach. However, cancer analysis and clas-
sification on the basis of microarray data
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Table 4 Small, round blue cell tumors top 15 markers
poses the challenge to develop computa-
tional procedures able to address specific
issues, such as modeling multiple, hetero-
geneous populations and reducing the
overwhelming number of variables (genes).
The present work addresses the imple-
mentation of a multivariate procedure that
allows marker identification by extracting
transcriptional features of physiological
state and sample diagnosis by classifying
tumor specimens through the supervised
analysis/comparison of expression profiles
from multiple tumor types. The gene selec-
tion and sample classification scheme is
based on Soft Independent Modeling of
Class Analogy (SIMCA) and relies on the
calibration of a principal component model
for each class present in the analyzed data
set. In the context of gene expression anal-
ysis, the original SIMCA design has been
adapted to solve the critical issue of feature
selection. In particular, specific subsets of
genes most highly correlated with several
tumor categories have been identified ex-
amining the variance structure explained
by each model and evaluating the perform-
ance of the classification scheme. SIMCA
procedure addresses the multiclass analysis
directly with no need to design and com-
bine binary classifiers or preliminary re-
duce the feature space.
Proof of concept has been given through
the analysis of two gene expression data-
bases, namely the data set from a work on
leukemia subtypes and a study on small
round blue cell tumors. The method has
been able to identify groups of genes that
could represent bases for subsequent ex-
perimental investigations. Moreover, the
classification procedure has been able to
distinguish with accuracy and robustness
between multiple tumor subtypes.
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